2023-07-17 16:34:19 ET
-
CEL-SCI ( NYSE: CVM ) plans to offer to sell shares of its common stock in an underwritten public offering, the company said Monday.
-
Shares of the company -24% at $2.15 after hours.
-
The underwriter has a 45-day option to purchase up to an additional 15% of shares to cover overallotments, if any.
-
All of the shares of common stock are being offered by CEL-SCI.
-
Pricing terms and the number of shares to be offered were not disclosed.
-
The net proceeds from the offering will be used to fund the continued development of Multikine and for general corporate purposes.
-
ThinkEquity is acting as the sole bookrunner.
For further details see:
CEL-SCI shares tumble on stock offering plans